Informed consent is a thing.
Most people facing a potentially crippling or lethal illness have a much greater risk tolerance against 'well maybe item 6 of 11 didn't do much to help here in retrospect' than you likely think.
That already happens often in routine practice anyway!
Again, the most useful points for a broad audience:
- get vaccine ASAP; prefer mRNA or Novavax; 2 doses far better than 1
- store RCT-validated early treatments: bromhexine-or-ambroxol + nitazoxanide-or-niclosamide, fluvoxamine, ivermectin
- N100 masks
https://t.co/DmV3mQOxPL
Remembered: badly needed to link the dual entry inhibition thread; people keep not recalling what it is.
Basically--
One of:
- bromhexine
- ambroxol
- maybe-camostat (but highest dose needed...)
And:
- Nitazoxanide
- Niclosamide
- RCT: HCQ (sry but yes)
https://t.co/DyxrurwEVg
If in doubt, *ask the patient*.
People have a fundamental right to participate in their own health-- *they already do so 99% of the time anyway*.
'This might help with X; it's a bit less certain; may cause Y side effects; studies say usually well-tolerated; do you want to try?'
Reuse of N95 and related masks, a review of 42 studies
https://t.co/PqnC5kzlrW
Comparison of merits of 5 different methods for retaining filtration
https://t.co/PqnC5kzlrW
@JAMA_current by @MSchumm90 and colleagues @UCLAHealth 😷
Efficacy is nowhere near Novavax or the mRNA options (Pfizer/Moderna).
Much like Sinovac/Sinopharm(/CanSino), the tell for this is the headline numbers focusing solely on severe COVID-19 and ignoring mild/moderate cases.
This truly is the time of the cicadas.
Every strategy with merit deserves its own time in the sun.
🌥️🌤️☀️
📈
Or moonlight, clandestine economy, filling gaps even at edges, choke points.
🌑🌒🌓🌔🌕🎴
Sometimes even spectacular.
Fly....
☄️
Glory to the forgetful.
⏳⌛
The continued failure to trial or use ITPP in critical care is an indictment against the regulatory and productive institutions of our supposedly-advanced (increasingly just shorthand for 'gridlocked') economy.
https://t.co/Jw64FfUtvA
It makes blood transport oxygen better.
The continued failure to trial or use ITPP in critical care is an indictment against the regulatory and productive institutions of our supposedly-advanced (increasingly just shorthand for 'gridlocked') economy.
https://t.co/Jw64FfUtvA
It makes blood transport oxygen better.
@patrickc@balajis
If you want a real impact in reducing ICU deaths, look into ITPP, while doing cyproheptadine and fluvoxamine.
Yes I know I am terrible with DMs.
Yes I know I am handicapped by pseudonymity. I will never use WhatsApp.
Just do it. My issues are irrelevant.